Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of the Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir regimen (with or without Ribavirin) in US veterans wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir (ombitasvir)
• Paritaprevir (paritaprevir)
• Ribavirin (ribavirin)
• Ritonavir (Ritonavir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C, Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2017-08-30